The Motley Fool
10 Oct 2026, 18:00 UTC · 2h ago
3 Reasons I'm Still Not Buying Tilray Stock -- Even at Penny-Stock Prices
Impact · against what's priced in
Tilray's recent financial results reinforce a bearish outlook as organic cannabis revenue continues to shrink and the company returns to a net loss. The apparent top-line growth is driven by acquisitions rather than operational efficiency, suggesting the current low valuation is justified by persistent unprofitability.
- TLRY−0.50
No priced-in read yet
- In context
The return to a net loss of $0.32 per share and a 13% decline in core cannabis revenue to $56.1 million signal a deterioration in the primary business, despite record total revenue driven by beverage acquisitions.
Read from the article alone
Search tags
